Gastrointestinal delivery of baculovirus displaying influenza virus hemagglutinin protects mice against heterologous H5N1 infection.
about
Recombinant baculovirus displayed vaccine: a novel tool for the development of a cross-protective influenza H5N1 vaccineHemagglutinin-based polyanhydride nanovaccines against H5N1 influenza elicit protective virus neutralizing titers and cell-mediated immunityDesign of a heterosubtypic epitope-based peptide vaccine fused with hemokinin-1 against influenza viruses.Strategies towards universal pandemic influenza vaccines.Viral vector-based influenza vaccines.Neutralizing epitopes of influenza virus hemagglutinin: target for the development of a universal vaccine against H5N1 lineages.Subcutaneous immunization with baculovirus surface-displayed hemagglutinin of pandemic H1N1 Influenza A virus induces protective immunity in mice.New strategies for the development of H5N1 subtype influenza vaccines: progress and challenges.Immunobiology of influenza vaccinesIntranasal immunization of baculovirus displayed hemagglutinin confers complete protection against mouse adapted highly pathogenic H7N7 reassortant influenza virusA recombinant vaccine of H5N1 HA1 fused with foldon and human IgG Fc induced complete cross-clade protection against divergent H5N1 viruses.Display of VP1 on the surface of baculovirus and its immunogenicity against heterologous human enterovirus 71 strains in miceRecombinant baculovirus associated with bilosomes as an oral vaccine candidate against HEV71 infection in miceMucosal delivery of ACNPV baculovirus driving expression of the Gal-lectin LC3 fragment confers protection against amoebic liver abscess in hamster.Protection against Amoebic Liver Abscess in Hamster by Intramuscular Immunization with an Autographa californica Baculovirus Driving the Expression of the Gal-Lectin LC3 FragmentAdaptive immune responses elicited by baculovirus and impacts on subsequent transgene expression in vivo.Construction of recombinant baculoviruses expressing hemagglutinin of H5N1 avian influenza and research on the immunogenicity.Insect cell technology is a versatile and robust vaccine manufacturing platform.Update on baculovirus as an expression and/or delivery vehicle for vaccine antigens.Oral vaccination with inactivated influenza vaccine induces cross-protective immunity.Structural and antigenic stability of H5N1 hemagglutinin trimer upon release from polyanhydride nanoparticles.Immune responses to baculovirus-displayed enterovirus 71 VP1 antigen.H5N1 influenza virus-like particles produced by transient expression in mammalian cells induce humoral and cellular immune responses in mice.Broadening the H5N3 Vaccine Immunogenicity against H5N1 Virus by Modification of Neutralizing Epitopes.Baculovirus Surface Display of Immunogenic Proteins for Vaccine Development
P2860
Q30221529-E5655E72-E56F-4C9F-91A8-07F75871F384Q30370494-F6F4F556-25EC-4D4D-97B8-CFB5F5FADF1CQ30373963-EA7F17BE-8F76-4B64-8BF8-CAA1767BD2DDQ30382226-B76F4DD6-3E5E-4981-8A8B-15AE049ACE6FQ30390938-5AF80A5F-EA27-42D0-8F35-48288BB467ACQ30393675-F66C3DED-2409-4CB0-A4EF-64C9720290E7Q30404811-B9BEC9DF-D2AC-4E68-B95F-BEFCFA1D9FBDQ30407424-3D8B8092-7124-459D-9257-CF977C8CF1C6Q30426771-744B2CAA-6E64-4810-B02F-B8BB400304B7Q30431867-04B18CE3-AC5D-43C8-9554-C1F47476D757Q33815195-A51DD7F1-5C47-408D-A419-C30D1A626B93Q33958090-5CB9D9DF-9C3B-4D9D-8B75-C58C966BFC66Q34580095-81B9A2E3-FE09-4348-A32F-F847A98BC752Q35565185-89E409FC-44AA-4887-A0FC-387D8B15E042Q35674433-42C79A13-12E5-4657-A3A2-A0B8F2298F40Q36759915-2B0869BA-E023-43B7-BEAA-EDF3DD371C71Q36785060-50C8F63B-E150-4010-948B-8896C11FA7B6Q37909427-935F0620-C225-4837-8351-B79EE944B264Q38243160-1B03F4ED-743D-405C-AAC0-A67435DFD838Q41378982-80CEFA39-0A3D-4CB0-A02D-2B77814CE215Q42242342-051E4E88-0B0A-4CEB-9582-4E41B5B92644Q43434704-37DAD2CD-0BBD-4C5A-A5A3-121690110E59Q45358893-289DAA65-52A6-45F7-9A4C-575DE370C734Q47558838-F132EAF7-E998-45F2-8AFB-8F678A8AF521Q56514706-D2A9CFED-9EC9-45DB-A6ED-73552738580E
P2860
Gastrointestinal delivery of baculovirus displaying influenza virus hemagglutinin protects mice against heterologous H5N1 infection.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Gastrointestinal delivery of b ...... t heterologous H5N1 infection.
@ast
Gastrointestinal delivery of b ...... t heterologous H5N1 infection.
@en
type
label
Gastrointestinal delivery of b ...... t heterologous H5N1 infection.
@ast
Gastrointestinal delivery of b ...... t heterologous H5N1 infection.
@en
prefLabel
Gastrointestinal delivery of b ...... t heterologous H5N1 infection.
@ast
Gastrointestinal delivery of b ...... t heterologous H5N1 infection.
@en
P2093
P2860
P356
P1433
P1476
Gastrointestinal delivery of b ...... t heterologous H5N1 infection.
@en
P2093
Mookkan Prabakaran
Nayana Prabhu
Selvaraj Madhan
P2860
P304
P356
10.1128/JVI.02175-09
P50
P577
2010-01-13T00:00:00Z